A Phase 1/Phase 2 Study of Polyvalent Pneumococcal Conjugate Vaccine (V116) in Adults (V116-001)

NCT04168190 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumonia, Pneumococcal

Interventions

BIOLOGICAL: V116
BIOLOGICAL: Pneumovax™23

Sponsor

Merck Sharp & Dohme LLC